title: In vitro evaluation of the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curves.
abstract: The objective of this study was to assess in vitro the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curves formed from dynamic contrast-enhanced ultrasound image loops. An indicator-dilution experiment was developed with an in vitro flow phantom setup used with SonoVue contrast agent (Bracco SpA, Milan, Italy). Imaging was performed with a Philips iU22 scanner and two transducers (L9-3 linear and C5-1 curvilinear). The following ultrasound scanner settings were investigated, along with contrast bolus volume: contrast-specific nonlinear pulse sequence, gain, mechanical index, focal zone depth, acoustic pulse center frequency and bandwidth. Four parameters (rise time, mean transit time, peak intensity, and area under the curve) were derived from time-intensity curves which were obtained after pixel by pixel linearization of log-compressed data (also referred to as video data) included in a region of interest. Rise time was found to be the parameter least impacted by changes to ultrasound scanner settings and contrast bolus volume; the associated coefficient of variation varied between 0.7% and 6.9% while it varied between 0.8% and 19%, 12% and 71%, and 9.2% and 66%, for mean transit time, peak intensity, and area under the curve, respectively. The present study assessed the impact of ultrasound scanner settings and contrast bolus volume on time-intensity curve analysis. One should be aware of these issues to standardize their technique in each specific organ of interest and to achieve accurate, sensitive, and reproducible data using dynamic contrast-enhanced ultrasound. One way to mitigate the impact of ultrasound scanner settings in longitudinal, multi-center quantitative dynamic contrast-enhanced ultrasound studies may be to prohibit any adjustments to those settings throughout a given study. Further clinical studies are warranted to confirm the reproducibility and diagnostic or prognostic value of time-intensity curve parameters measurements in a particular clinical scenario of interest, for example that of cancer patients undergoing vascular targeting therapies.
authors: Philips Ultrasound, Bothell, WA, USA. thomas.gauthier@philips.com
authors: Thomas P
authors: TP
authors: Gauthier
authors: Mohamed
authors: M
authors: Chebil
authors: Pierre
authors: P
authors: Peronneau
authors: Nathalie
authors: N
authors: Lassau
mesh_terms: D019540:Area Under Curve; D003287:Contrast Media; D007089:Image Enhancement / Q000379:methods; D007091:Image Processing, Computer-Assisted; D066298:In Vitro Techniques; D007201:Indicator Dilution Techniques; D009369:Neoplasms / Q000188:drug therapy; D019047:Phantoms, Imaging; D010743:Phospholipids; D013459:Sulfur Hexafluoride; D013997:Time Factors; D014159:Transducers; D014463:Ultrasonography / Q000379:methods*
chemical_list: D003287:Contrast Media; D010743:Phospholipids; C420843:contrast agent BR1; D013459:Sulfur Hexafluoride